Quick answer
"Semaglutide research" usually means one of two things: understanding the GLP-1 mechanism, or trying to figure out if a given batch of material is actually what the label says. This guide is about the second problem — what counts as real documentation versus a supplier just asserting quality, and how to check the difference before you order. The Peptide Lab doesn't carry a semaglutide SKU. Its metabolic-category catalogue depth is on retatrutide, the compound most researchers end up comparing semaglutide against anyway. If your work needs semaglutide specifically, everything below still applies — it's about what to ask any supplier, not a pitch for one.
Why semaglutide is the reference compound
Semaglutide is the most studied, most widely available molecule in the incretin pathway, and it's the baseline every newer GLP-1, GIP, or triple-agonist compound gets measured against. That's a mechanism question, not a sourcing one. The semaglutide explainer covers how GLP-1 receptor agonism works, the three downstream effects on appetite, gastric emptying, and glucose regulation, and where semaglutide sits next to newer compounds. This guide starts where that one ends: once you know what semaglutide is, how do you tell if a specific vial of it is real?
What documentation actually proves
"Research-grade" gets used as a marketing word more than a verifiable claim, and most of the damage happens in the gap between the two. Four things separate a supplier that can back up its material from one that's just saying the right words.
Purity and content are different numbers, and suppliers rarely explain that. Purity, usually reported via HPLC, tells you what fraction of the material is the target molecule versus synthesis byproducts. Content, sometimes called mass, tells you how much of that molecule is actually in the vial relative to the labeled amount. A supplier can post a strong purity number while under-filling vials. Those are two separate measurements, and a real report gives you both.
Documentation also needs to be tied to the specific batch, not the product line. A test result linked to a lot number that matches what's printed on your vial means something. A generic "we test everything" page doesn't, because it tells you nothing about the vial in front of you. If the lot number on your order doesn't map to a specific report, you're reading marketing copy, not a test result.
Identity confirmation is the other half of the picture, and it needs a second method. HPLC tells you how clean the material is. Mass spectrometry tells you the molecule is actually semaglutide — matching its roughly 4,100 Da molecular weight — rather than something structurally close but wrong. A supplier that only runs one of the two tests is handing you half an answer.
And then there's who ran the test. In-house testing means the supplier is grading its own material. That's standard practice and worth having, but it isn't the same claim as independent testing, where an outside lab ran the analysis and the supplier is showing you someone else's result. Both matter. What's worth noticing is a supplier who blurs the two together, or lets you assume one when they mean the other.
| What to check | Weak signal | Strong signal |
|---|---|---|
| Purity reporting | Single "purity" percentage, no method named | HPLC purity and content/mass reported separately |
| Identity confirmation | Purity claim only | HPLC plus mass spec matching expected molecular weight |
| Documentation scope | Generic "we test everything" page | Result tied to the specific lot number on the vial |
| Testing source | Unclear whether in-house or independent | Explicit statement of which one, and how to verify it |
| Certification cost | No option to add independent testing at all | Independent third-party certification offered, even as a paid add-on |
The Peptide Lab's standard is in-house HPLC purity and mass-spec identity testing on every batch before it's listed, with the result tied to the lot number — that's the default, included in the price, described at /quality. Independent third-party US-lab certification is a separate, optional line item at checkout: $100 per order, for buyers who want an outside lab's confirmation on top of the standard release testing. That's not the same claim as "every batch ships with independent certification," and a supplier who elides the two is worth a second look. Whichever supplier you're evaluating for semaglutide, ask directly which category their testing falls into.
When retatrutide is the better fit
If semaglutide is your reference point mainly because it's the most familiar GLP-1 compound, it's worth checking whether your actual question is better served by retatrutide — a triple agonist hitting GLP-1, GIP, and glucagon receptors, and the compound most often framed as "the next one after semaglutide." The retatrutide vs Ozempic comparison covers the mechanism and trial data side by side, and the retatrutide explainer covers the triple-agonist mechanism on its own. The Peptide Lab's metabolic-category catalogue depth is on retatrutide, not semaglutide, so if your protocol can use either compound, that's the one available to order directly — with the same in-house testing standard, and the same optional certification, described above.
For a field-by-field walkthrough of what each line on a report actually means, see the peptide COA guide.
